ReviewCell communication and signaling : CCS2026
The dual role of the microbiome in chronic wound management.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chronic wounds are characterized by delayed healing driven by persistent dysbiosis of the wound microbiome. Distinct microbial communities, often organized as biofilms, dominate different chronic wound types and impair tissue repair through metabolic disruption, immune evasion, and sustained inflammation. Emerging evidence indicates that probiotics can modulate wound-associated microbiota by suppressing pathogenic colonization, reshaping local metabolic and immune responses, and promoting a pro-regenerative microenvironment, both locally and via the gut-skin axis. Recent advances in natural product-derived biomaterials provide new opportunities to enable probiotic-based interventions through controlled delivery and protection of microbial function. This review summarizes the dual role of the microbiome in chronic wound pathology and healing, evaluates the challenges and risks of probiotic therapies, and highlights microbiome-responsive materials as translational tools. We propose that targeted microbiome interventions should evolve through a closed-loop strategy integrating microbiome profiling, strengthened product and technology development, and adaptive clinical management to achieve precision wound care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.